liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
Ludvigsson, Johnny, ProfessorORCID iD iconorcid.org/0000-0003-1695-5234
Alternative names
Publications (10 of 418) Show all publications
Das, D. & Ludvigsson, J. (2026). Early Childhood Stress and the Risk of Developing Psoriasis: A Cohort Study. Journal of Investigative Dermatology, 146(4), 1028-1033
Open this publication in new window or tab >>Early Childhood Stress and the Risk of Developing Psoriasis: A Cohort Study
2026 (English)In: Journal of Investigative Dermatology, ISSN 0022-202X, E-ISSN 1523-1747, Vol. 146, no 4, p. 1028-1033Article in journal (Refereed) Published
Abstract [en]

Environmental factors play a role in onset of psoriasis. We investigated whether early childhood stress contributes to the development of psoriasis later in life. Questionnaires, answered by parents of children in the All Babies in Southeast Sweden prospective birth cohort (n = 16,145) follow-up at 1, 3, 5, and 8 years of the child, were used. Psoriasis cases were identified using the Swedish National Patient Register. Statistical analyses were conducted using the R programming language. The stress life factor "new family structure" (divorce/separation and/or new adult or new/step siblings) before the age of 1 year increased the risk of developing psoriasis (OR = 4.19, 95% confidence interval = 1.01-11.48, P = .048) in the univariate regression model and was also significant when adjusted for confounders. Integrating data from follow-up years 1, 3, 5, and 8, "new family structure" increased the risk of psoriasis-univariate (OR = 3.40, 95% confidence interval = 1.06-9.42, P = .04) but was not significant in the adjusted multivariable model, although the effect size was high (OR = 2.91, 95% confidence interval = 0.88-8.41). Children experiencing the psychological stress of a "new family structure" during the first 8 years of life have an increased risk of developing psoriasis later.

Place, publisher, year, edition, pages
Elsevier, 2026
Keywords
ABIS; General population; Prospective; Psoriasis; Stressful life factors (SLF)
National Category
Dermatology and Venereal Diseases Pediatrics
Identifiers
urn:nbn:se:liu:diva-221854 (URN)10.1016/j.jid.2025.08.026 (DOI)001721455200001 ()40907601 (PubMedID)2-s2.0-105024960967 (Scopus ID)
Funder
Swedish Research Council, K2008-69X-20826-01-4Swedish Research Council, K2005-72X-11242-11ASwedish Diabetes AssociationMedical Research Council of Southeast Sweden (FORSS)
Available from: 2026-03-12 Created: 2026-03-12 Last updated: 2026-04-22
Allen, L. A., Taylor, P. N., Carlsson, A., Fraser, D. P., Hagopian, W. A., Hedlund, E., . . . Oram, R. A. (2026). Relative maternal protection against type 1 diabetes: A combined analysis of 5 observational studies. Journal of Clinical Endocrinology and Metabolism, 111(8), 2262-2274
Open this publication in new window or tab >>Relative maternal protection against type 1 diabetes: A combined analysis of 5 observational studies
Show others...
2026 (English)In: Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, E-ISSN 1945-7197, Vol. 111, no 8, p. 2262-2274Article in journal (Refereed) Published
Abstract [en]

Context: Maternal (versus paternal) type 1 diabetes is associated with a relative reduction in type 1 diabetes risk in offspring during early life. Objective: To determine whether this effect extends into later life. To clarify the importance of intrauterine exposure to maternal type 1 diabetes, and baseline genetic susceptibility in this context. Methods: We compared the proportion of individuals with type 1 diabetes diagnosed age 0-88 years with affected mothers and fathers across five observational studies (n=11,475), and used random-effects meta-analyses to generate overall effect estimates. We examined this by age at diagnosis, and timing of parental diagnosis relative to offspring birth. We compared the type 1 diabetes genetic risk score (T1D-GRS2) of individuals with affected mothers and fathers. Results: Almost half as many individuals with type 1 diabetes had an affected mother versus father (OR 0.55 (95% CI 0.48, 0.64), p<0.0001). A lower proportion of individuals with affected mothers than fathers was apparent even amongst individuals diagnosed as adults (>18 years) (OR 0.63 (95% CI 0.43, 0.91), p=0.01). The lower proportion of individuals with maternal versus paternal type 1 diabetes was only observed if maternal diagnosis preceded offspring birth (OR 0.51 (95% CI 0.37, 0.70), p<0.001 versus OR 0.97 (95% CI 0.69, 1.38), p=0.87 after birth). T1D-GRS2 was similar between individuals with affected mothers and fathers (p=0.25). Conclusion: Our analyses suggest intrauterine exposure to maternal type 1 diabetes is associated with long-lasting relative protection against offspring type 1 diabetes, which is independent of genetic susceptibility as measured by T1D-GRS2.

Place, publisher, year, edition, pages
ENDOCRINE SOC, 2026
Keywords
familial; family; maternal; offspring; paternal; protection; transmission; type 1 diabetes
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-222516 (URN)10.1210/clinem/dgag103 (DOI)001728456000001 ()41810517 (PubMedID)2-s2.0-105044660090 (Scopus ID)
Note

Funding Agencies|Wellcome Trust [225446/Z/22/Z]

Available from: 2026-04-10 Created: 2026-04-10 Last updated: 2026-11-03Bibliographically approved
Ludvigsson, J. (2026). The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter] [Letter to the editor]. Diabetologia, 69(5), 1384-1385, Article ID PMID 6777.
Open this publication in new window or tab >>The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter]
2026 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 69, no 5, p. 1384-1385, article id PMID 6777Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages
SPRINGER, 2026
Keywords
Beta cell function; Beta cell mass; Beta cell stress; Insulin sensitivity; Physical activity; Prevention; Type 1 diabetes; Type 2 diabetes
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-221576 (URN)10.1007/s00125-026-06689-3 (DOI)001692665500001 ()41699124 (PubMedID)2-s2.0-105030151061 (Scopus ID)
Available from: 2026-03-03 Created: 2026-03-03 Last updated: 2026-09-17Bibliographically approved
Das, D. & Ludvigsson, J. (2025). Cord Blood Biomarkers Predict Psoriasis Many Years Before Diagnosis: A Prospective Birth Cohort Study. Archives of Clinical and Biomedical Research, 9(3), 203-211
Open this publication in new window or tab >>Cord Blood Biomarkers Predict Psoriasis Many Years Before Diagnosis: A Prospective Birth Cohort Study
2025 (English)In: Archives of Clinical and Biomedical Research, E-ISSN 2572-5017, Vol. 9, no 3, p. 203-211Article in journal (Refereed) Published
Abstract [en]

Background: This study aimed to identify biomarkers that can serve as putative predictors for different groups based on psoriasis diagnosis, onset, and severity, with the clinical implication of decreasing the risk of developing the disease.

Material and Methods: Multiple protein biomarkers were assessed in cord blood from 115 psoriasis affected cases and 220 healthy controls in ABIS (All Babies in Southeast Sweden) by proximity extension assay (PEA).

Results: IFNGR1, COLEC12, and TNFRSF11B had higher expression in cases while 50 had a higher expression in controls, especially STX.8, COL9A1, HLA-E, PLXNA4, RAB37, EDAR, and CD84. Gene Ontology enrichment with all annotated proteins reveals that IFNGR1 is enriched in GO terms, whereas TNFRSF was enriched in GO terms. The same two proteins were found significant using ANOVA with sex, and gestational age as covariates and same GO terms were enriched. Number of significantly different biomarkers in the onset groupings were 28, 57, and 41 for "healthy - post puberty psoriasis”, “healthy - pre puberty psoriasis" and "post puberty psoriasis - pre puberty psoriasis", respectively. Similarly, we found 70, 24, and 61 differentially expressed proteins for “healthymild”, “healthy-severe”, and “mild-severe” comparisons.

Conclusions: Several proteins were increased already in cord blood of individuals who later developed psoriasis, but even more proteins usually related to immune system and/or skin structure were significantly reduced in these individuals. This suggests that factors already during pregnancy may play a role for development of psoriasis. However, we found no significant association to environmental factors during pregnancy.

Place, publisher, year, edition, pages
Fortune Journals, 2025
Keywords
Psoriasis, ABIS, IFNGR1, Normalized Protein Expression (NPX), olink, Autoimmunity, Biomarkers
National Category
Dermatology and Venereal Diseases
Identifiers
urn:nbn:se:liu:diva-221351 (URN)10.26502/acbr.50170452 (DOI)
Note

Funding agencies: Barndiabetesfonden (Swedish Child Diabetes Foundation); Swedish Research Council, Grant/Award Numbers: K200572X-11242-11A and K2008-69X-20826-01-4, K200869X-20826-01-4; Medical Research Council of Southeast Sweden (FORSS); JDRF Wallenberg Foundation, Grant/ Award Number: K 98-99D-12813-01A; ALF grants from Region Östergötland and Linköping University, Sweden, and the Joanna Cocozza Foundation.

Available from: 2026-02-18 Created: 2026-02-18 Last updated: 2026-04-27
Lerchova, T., Ludvigsson, J., Mårild, S., Imberg, H., Andersson, B., Størdal, K. & Mårild, K. (2025). Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study. Inflammatory Bowel Diseases, 31(12), 3327-3336
Open this publication in new window or tab >>Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study
Show others...
2025 (English)In: Inflammatory Bowel Diseases, ISSN 1078-0998, E-ISSN 1536-4844, Vol. 31, no 12, p. 3327-3336Article in journal (Refereed) Published
Abstract [en]

Introduction Childhood overweight and obesity are emerging global health issues with potential implications for immune function. We aimed to investigate childhood body mass index (BMI) as a risk factor for later inflammatory bowel disease (IBD).Methods ABIS (Sweden) and MoBa (Norway) are population-based cohorts following participants prospectively from birth (1997-2009) until 2023. We retrieved anthropometric data at birth, 1, 3, and 7-8 years to examine the association of age-specific standardized BMI percentiles and categories (underweight, normal [reference), overweight, obesity) with later IBD. We also analyzed IBD risk according to BMI trajectories across ages. IBD diagnosis was identified in national health registries. Cohort-specific hazard ratios (aHRs) were adjusted for sociodemographics, parental BMI, IBD, and smoking and pooled using a random-effects model.Results Overall, among 54 890 children with 803 444 person-years of follow-up, we identified 246 IBD events. Eight-year-olds living with obesity had a 5-fold increased risk of ulcerative colitis (pooled aHR = 5.10; 95% CI , 1.51-17.27), but not a significantly increased risk of Crohn's disease (pooled aHR = 1.38; 95% CI , 0.24-7.98) and IBD overall (pooled aHR = 1.89; 95% CI , 0.71-5.04). Children with overweight or obesity at age 3 had no increased risk of IBD compared to normal-weight children (pooled aHR = 1.15, 95% CI , 0.74-1.77; and 1.05, 95% CI , 0.43-2.58, respectively). Early-life BMI trajectories were not consistently associated with IBD.Conclusion In this Scandinavian birth cohort, 7-8 year-old children with obesity had an increased risk of developing ulcerative colitis later in life. Given the high prevalence of childhood obesity, this observation should be corroborated and possible mechanisms behind the association clarified.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS INC, 2025
Keywords
obesity; ulcerative colitis; childhood
National Category
Nutrition and Dietetics
Identifiers
urn:nbn:se:liu:diva-217179 (URN)10.1093/ibd/izaf167 (DOI)001555852900001 ()40854285 (PubMedID)2-s2.0-105024471911 (Scopus ID)
Note

Funding Agencies|K.M. Birgitta och Gran Karlssons Stiftelse; Norwegian Ministry of Health and Care Services; Ministry of Education and Research

Available from: 2025-09-02 Created: 2025-09-02 Last updated: 2026-04-07Bibliographically approved
Bélteky, M., Wahlberg, J. & Ludvigsson, J. (2025). Infections and antibiotic use in early childhood have limited importance in developing manifest type 1 diabetes - The ABIS cohort study. Frontiers in Endocrinology, 16, Article ID 1529447.
Open this publication in new window or tab >>Infections and antibiotic use in early childhood have limited importance in developing manifest type 1 diabetes - The ABIS cohort study
2025 (English)In: Frontiers in Endocrinology, E-ISSN 1664-2392, Vol. 16, article id 1529447Article in journal (Refereed) Published
Abstract [en]

Aims

To investigate the effect of early childhood infections and antibiotic use on the risk of type 1 diabetes in a general population cohort.

Research Design and Methods

The All Babies In Southeast Sweden (ABIS) cohort followed 16 428 children from birth. Questionnaires collected at 1 year (n=11 093), 3 years (n=8 890) and 5 years of age (n=7 445) included data on infections and antibiotic use and were validated against national registers. After a mean follow-up of 25 years, 168 individuals have been diagnosed with type 1 diabetes (1.0 % of the original cohort, aged 1-24.5 years).

Results

There were few significant differences in type or frequency of early childhood infections or antibiotic use between cases with type 1 diabetes and the reference group (remaining individuals who did not develop type 1 diabetes) after adjusting for sex, heredity and socioeconomic status. A small number of type 1 diabetes children (4.8 % compared to 0.8 % of the reference group) reported six or more episodes of gastroenteritis in the 1-3-year age group, resulting in an adjusted odds ratio (aOR) of 8.21; 95 % CI 2.70-25.01, p<0.001. Cases of type 1 diabetes with an increased genetic risk (n=91) reported fewer episodes of the common cold between 1 and 3 years of age compared to the reference group (aOR 0.27; 0.13-0.58, p<0.001). Individuals with type 1 diabetes without risk-associated HLA alleles (n=14) reported a higher frequency of pneumonia in the 1–3- and 3–5-year age group (aOR 26.08; 6.29-108.17, p<0.001 and aOR 35.63; 4.10-309.96, p=0.001 respectively), and had more viral and total infections registered in the National Patient Register from 0-5 years (aOR 5.72; 1.59-20.57, p=0.008 and aOR 18.71; 1.95-179.55, p=0.01).

Conclusions

Childhood infections could increase the risk of developing type 1 diabetes in a small group of individuals without risk-associated HLA alleles, but this was not seen in the majority with HLA-risk. More research is required for this overlooked population, including screening and prevention trials. The association to frequent gastrointestinal infections in the first years of life needs to be reproduced in other studies to be confirmed. 

Place, publisher, year, edition, pages
Frontiers Media S.A., 2025
Keywords
childhood environmental factors, Gastroenteritis, Infections, sex differences, type 1 diabetes
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-211370 (URN)10.3389/fendo.2025.1529447 (DOI)001438813800001 ()40060384 (Scopus ID)
Note

Funding Agencies|Barndiabetesfonden (Swedish Child Diabetes Foundation Swedish Research Council) [K2005-72X-11242-11A, K2008-69X-20826-01-4]; Medical Research Council of Southeast Sweden (FORSS); JDRF Wallenberg Foundation [K 98-99D-12813-01A]; ALF-grants; Clinical research project; Joanna Cocozza Foundation

Available from: 2025-02-04 Created: 2025-02-04 Last updated: 2025-05-14
Fatulla, P., Ludvigsson, J., Imberg, H., Nyström, T. & Lind, M. (2025). Retinopathy and nephropathy in type 1 diabetes: role of HbA1c and blood pressure variability. Acta Diabetologica, 62(12), 2235-2238
Open this publication in new window or tab >>Retinopathy and nephropathy in type 1 diabetes: role of HbA1c and blood pressure variability
Show others...
2025 (English)In: Acta Diabetologica, ISSN 0940-5429, E-ISSN 1432-5233, Vol. 62, no 12, p. 2235-2238Article in journal (Refereed) Published
Abstract [en]

Aims To examine the association between within-person variability in glycated hemoglobin A1c (HbA1c) and blood pressure (BP) with retinopathy and nephropathy in type 1 diabetes (T1D). Methods This nationwide cohort included 9,358 individuals from the Swedish National Diabetes Register with T1D &lt;5 years at inclusion (1998-2017) and &gt;= 8 years follow-up. Variability in HbA1c, systolic BP (SBP), and diastolic BP (DBP) was calculated as updated SDs. Associations with microvascular complications were analyzed using logistic regression with generalized estimating equations, adjusted for demographic and clinical covariates. Results Mean age at inclusion was 14.2 years, mean diabetes duration 1.2 years, and 44% were female. Over 10.7 years' follow-up, retinopathy developed in 33% and nephropathy in 9.3%. SBP variability was significantly associated with pre-proliferative or proliferative retinopathy (aOR 1.13, 95% CI 1.00-1.27) and proliferative retinopathy/ laser photocoagulation (1.23, 1.04-1.45), as well as with any albuminuria (1.15, 1.08-1.23) and macroalbuminuria (1.29, 1.15-1.45). DBP variability was associated with any albuminuria (1.11, 1.03-1.19) and macroalbuminuria (1.28, 1.10-1.50). HbA1c variability was associated with any retinopathy (1.14, 1.08-1.20) and any albuminuria (1.12, 1.03-1.21). Conclusions Beyond mean levels, higher variability in HbA1c and BP is associated with retinopathy and nephropathy. Stable BP control in patients with established retinopathy may be important to prevent progression to sight-threatening stages.

Place, publisher, year, edition, pages
SPRINGER-VERLAG ITALIA SRL, 2025
Keywords
Type 1 diabetes; HbA1c variability; Blood pressure variability; Retinopathy; Nephropathy; Microvascular complications
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-218150 (URN)10.1007/s00592-025-02575-3 (DOI)001574351800001 ()40960629 (PubMedID)2-s2.0-105016634081 (Scopus ID)
Note

Funding Agencies|University of Gothenburg

Available from: 2025-09-30 Created: 2025-09-30 Last updated: 2026-02-24Bibliographically approved
Teixeira, P. F., Battelino, T., Carlsson, A., Gudbjörnsdottir, S., Hannelius, U., von Herrath, M., . . . Forsander, G. (2024). Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data. Diabetologia, 67(6), 985-994
Open this publication in new window or tab >>Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
Show others...
2024 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 67, no 6, p. 985-994Article in journal (Refereed) Published
Abstract [en]

The type 1 diabetes community is coalescing around the benefits and advantages of early screening for disease risk. To be accepted by healthcare providers, regulatory authorities and payers, screening programmes need to show that the testing variables allow accurate risk prediction and that individualised risk-informed monitoring plans are established, as well as operational feasibility, cost-effectiveness and acceptance at population level. Artificial intelligence (AI) has the potential to contribute to solving these issues, starting with the identification and stratification of at-risk individuals. ASSET (AI for Sustainable Prevention of Autoimmunity in the Society; www.asset.healthcare) is a public/private consortium that was established to contribute to research around screening for type 1 diabetes and particularly to how AI can drive the implementation of a precision medicine approach to disease prevention. ASSET will additionally focus on issues pertaining to operational implementation of screening. The authors of this article, researchers and clinicians active in the field of type 1 diabetes, met in an open forum to independently debate key issues around screening for type 1 diabetes and to advise ASSET. The potential use of AI in the analysis of longitudinal data from observational cohort studies to inform the design of improved, more individualised screening programmes was also discussed. A key issue was whether AI would allow the research community and industry to capitalise on large publicly available data repositories to design screening programmes that allow the early detection of individuals at high risk and enable clinical evaluation of preventive therapies. Overall, AI has the potential to revolutionise type 1 diabetes screening, in particular to help identify individuals who are at increased risk of disease and aid in the design of appropriate follow-up plans. We hope that this initiative will stimulate further research on this very timely topic.

Place, publisher, year, edition, pages
SPRINGER, 2024
Keywords
AI; Artificial intelligence; ASSET; Children; Precision medicine; Prevention; Screening; Type 1 diabetes
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-201171 (URN)10.1007/s00125-024-06089-5 (DOI)001161703400001 ()38353727 (PubMedID)2-s2.0-85185118015 (Scopus ID)
Note

Funding Agencies|VINNOVA

Available from: 2024-02-26 Created: 2024-02-26 Last updated: 2025-03-18Bibliographically approved
Das, D., Thimjo, J., Lebena, A., Guo, A., Enerbäck, C. & Ludvigsson, J. (2024). Breastfeeding decreases the risk of developing psoriasis through to early adulthood. British Journal of Dermatology, 191(1), 65-74
Open this publication in new window or tab >>Breastfeeding decreases the risk of developing psoriasis through to early adulthood
Show others...
2024 (English)In: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 191, no 1, p. 65-74Article in journal (Refereed) Published
Abstract [en]

Background Psoriasis is a genetically determined systemic skin disease, although environmental trigger factors are required for disease manifestation. Some of these triggers, such as stress, infections and drug exposure, have been identified. Objectives To explore the role of early nutrition as a risk factor for the development of psoriasis. Methods Parents in the All Babies in Southeast Sweden (ABIS) prospective birth cohort (n = 16 415) answered questionnaires at birth and when their children were aged 1 and 3 years. A diagnosis of psoriasis was determined from the Swedish National Patient Register and National Drug Prescription Register. Statistical analyses were conducted using custom-written R scripts. Results Individuals breastfed for &lt; 4 months and who received infant formula before 4 months of age had a higher risk of psoriasis [odds ratio (OR) 1.84 (P = 0.02) and OR 1.88 (P = 0.02), respectively]. At the 3-year follow-up, the increased consumption of fish, especially from the Baltic Sea, increased the risk of psoriasis (OR 9.61; P = 0.003). In addition, the risk of psoriasis increased following the consumption of a large volume of milk (OR 2.53; P = 0.04). Conclusions Our study underscores, for the first time, the impact of very early nutrition on the manifestation of psoriasis through early adulthood. Exclusive breastfeeding for 4 months appears to be protective.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS, 2024
National Category
Dermatology and Venereal Diseases
Identifiers
urn:nbn:se:liu:diva-202352 (URN)10.1093/bjd/ljae043 (DOI)001184403800001 ()38305572 (PubMedID)2-s2.0-85196763502 (Scopus ID)
Note

Funding Agencies|Barndiabetesfonden (Swedish Child Diabetes Foundation); Swedish Council for Working Life and Social Research [FAS2004-1775]; Swedish Research Council [K2005-72X-11242-11A, K2008-69X-20826-01-4]; Ostgota Brandstodsbolag; Medical Research Council of Southeast Sweden (FORSS); JDRF Wallenberg Foundation [K98-99D-12813-01A]; Region Ostergotland; Linkoping University, Sweden; Joanna Cocozza Foundation

Available from: 2024-04-12 Created: 2024-04-12 Last updated: 2025-02-18Bibliographically approved
Lind, A., Freyhult, E., Ramelius, A., Bennet, R., Robinson, P. V., Seftel, D., . . . Lernmark, Å. (2024). Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays. EBioMedicine, 104, Article ID 105144.
Open this publication in new window or tab >>Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
Show others...
2024 (English)In: EBioMedicine, E-ISSN 2352-3964, Vol. 104, article id 105144Article in journal (Refereed) Published
Abstract [en]

Background: Two or more autoantibodies against either insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A) or zinc transporter 8 (ZnT8A) denote stage 1 (normoglycemia) or stage 2 (dysglycemia) type 1 diabetes prior to stage 3 type 1 diabetes. Automated multiplex Antibody Detection by Agglutination-PCR (ADAP) assays in two laboratories were compared to single plex radiobinding assays (RBA) to define threshold levels for diagnostic specificity and sensitivity.

Methods: IAA, GADA, IA-2A and ZnT8A were analysed in 1504 (54% females) population based controls (PBC), 456 (55% females) doctor's office controls (DOC) and 535 (41% females) blood donor controls (BDC) as well as in 2300 (48% females) patients newly diagnosed (1-10 years of age) with stage 3 type 1 diabetes. The thresholds for autoantibody positivity were computed in 100 10-fold cross-validations to separate patients from controls either by maximizing the χ2-statistics (chisq) or using the 98th percentile of specificity (Spec98). Mean and 95% CI for threshold, sensitivity and specificity are presented.

Findings: The ADAP ROC curves of the four autoantibodies showed comparable AUC in the two ADAP laboratories and were higher than RBA. Detection of two or more autoantibodies using chisq showed 0.97 (0.95, 0.99) sensitivity and 0.94 (0.91, 0.97) specificity in ADAP compared to 0.90 (0.88, 0.95) sensitivity and 0.97 (0.94, 0.98) specificity in RBA. Using Spec98, ADAP showed 0.92 (0.89, 0.95) sensitivity and 0.99 (0.98, 1.00) specificity compared to 0.89 (0.77, 0.86) sensitivity and 1.00 (0.99, 1.00) specificity in the RBA. The diagnostic sensitivity and specificity were higher in PBC compared to DOC and BDC.

Interpretation: ADAP was comparable in two laboratories, both comparable to or better than RBA, to define threshold levels for two or more autoantibodies to stage type 1 diabetes.

Funding: Supported by The Leona M. and Harry B. Helmsley Charitable Trust (grant number 2009-04078), the Swedish Foundation for Strategic Research (Dnr IRC15-0067) and the Swedish Research Council, Strategic Research Area (Dnr 2009-1039). AL was supported by the DiaUnion collaborative study, co-financed by EU Interreg ÖKS, Capital Region of Denmark, Region Skåne and the Novo Nordisk Foundation.

Place, publisher, year, edition, pages
Elsevier, 2024
Keywords
Antibody detection by agglutination PCR; Diagnostic sensitivity; Diagnostic specificity; GAD65 autoantibodies; IA-2 autoantibodies; Insulin autoantibodies; Radiobinding assay; Type 1 diabetes; ZnT8 autoantibodies
National Category
Endocrinology and Diabetes
Identifiers
urn:nbn:se:liu:diva-212802 (URN)10.1016/j.ebiom.2024.105144 (DOI)38723553 (PubMedID)
Available from: 2025-04-03 Created: 2025-04-03 Last updated: 2025-05-21
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-1695-5234

Search in DiVA

Show all publications